Kallikrein 7 anticorps (C-Term)
Aperçu rapide pour Kallikrein 7 anticorps (C-Term) (ABIN5531504)
Antigène
Voir toutes Kallikrein 7 (KLK7) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 157-187, C-Term
-
Purification
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis
-
Immunogène
- This Kallikrein 7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 157-187 amino acids from the C-terminal region of human Kallikrein 7.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
-
For WB starting dilution is: 1:1000
For IHC-P starting dilution is: 1:10~50
For FACS starting dilution is: 1:10~50 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 2 mg/mL
-
Buffer
- Supplied in PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- Kallikrein 7 (KLK7)
-
Autre désignation
- Kallikrein 7
-
Sujet
- Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. The KLK7 enzyme is thought to be involved in the proteolysis of intercellular cohesive structures preceding desquamation, which is the shedding of the outermost layer of the epidermis.
-
Poids moléculaire
- 28 kDa
-
ID gène
- 5650
-
UniProt
- P49862
-
Pathways
- Système du Complément
Antigène
-